Key facts
- Oxyle’s last known valuation is $40.4M (Jan 2025).
- It has raised $18.5M; the latest was Seed Round ($18.5M) in Jan 2025.
- Notable investors include MassChallenge, European Innovation Council, SOSV, Venture Kick, Venture (Switzerland) — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Oxyle
- ·The full record, as it builds
Funding rounds
No funding rounds for Oxyle are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oxyle
Developer of a wastewater conversion technology designed to prevent toxic and persistent micropollutants from cost-effectively entering water bodies. The company's system provides regulatory relief to various customer segments, such as chemical industries, hospitals, and biotech companies, by eliminating a wide range of toxic and persistent organic pollutants from wastewater, enabling clients to eliminate wastewater incineration and reduce carbon dioxide emissions.
- Sector
- Business Products and Services (B2B)
- HQ
- Zurich, Switzerland
- Employees
- 37
- Website
- oxyle.com/
- Ownership
- Privately Held (backing)
Oxyle doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oxyle shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oxyle in its N-PORT filings yet. We sweep new filings monthly.